We are live on ! Find out more
GEA

Glen Eagle Advisors Portfolio holdings

AUM $714M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+18.87%
3 Year Est. Return
+62.99%
5 Year Est. Return
+76.32%
10 Year Est. Return
AUM
$322M
AUM Growth
+$35.3M
Cap. Flow
+$17M
Cap. Flow %
5.28%
Top 10 Hldgs %
30.83%
Holding
1,070
New
67
Increased
247
Reduced
122
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 12.22%
2 Healthcare 10.01%
3 Financials 6.51%
4 Consumer Discretionary 4.83%
5 Communication Services 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTRG icon
101
Essential Utilities
WTRG
$11.2B
$718K 0.22%
15,710
+735
+5% +$34.5K
LOW icon
102
Lowe's Companies
LOW
$115B
$717K 0.22%
3,699
+77
+2% +$15.1K
VV icon
103
Vanguard Large-Cap ETF
VV
$52.5B
$710K 0.22%
3,539
+130
+4% +$25.4K
LHX icon
104
L3Harris
LHX
$53.1B
$708K 0.22%
3,274
DOCU
105
DocuSign
DOCU
$9.14B
$676K 0.21%
2,417
-9
-0.4% -$2.01K
IVW icon
106
iShares S&P 500 Growth ETF
IVW
$74.2B
$672K 0.21%
9,238
-75
-0.8% -$5.19K
DUK icon
107
Duke Energy
DUK
$99.7B
$655K 0.2%
6,633
-31
-0.5% -$3.11K
AMGN icon
108
Amgen
AMGN
$198B
$645K 0.2%
2,647
-54
-2% -$13.3K
NFLX icon
109
Netflix
NFLX
$285B
$629K 0.2%
11,910
MRK icon
110
Merck
MRK
$315B
$626K 0.19%
8,053
-34
-0.4% -$2.53K
SPYG icon
111
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.9B
$624K 0.19%
9,908
+3,310
+50% +$199K
BXMX
112
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$621K 0.19%
43,232
+512
+1% +$7.21K
IJT icon
113
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.26B
$617K 0.19%
4,652
+410
+10% +$53.4K
LRCX icon
114
Lam Research
LRCX
$399B
$608K 0.19%
9,340
+2,270
+32% +$143K
TMO icon
115
Thermo Fisher Scientific
TMO
$196B
$604K 0.19%
1,198
-34
-3% -$16K
VUG icon
116
Vanguard Growth ETF
VUG
$222B
$603K 0.19%
12,612
+3,888
+45% +$177K
ZTS icon
117
Zoetis
ZTS
$31.1B
$591K 0.18%
3,172
+872
+38% +$151K
ADP icon
118
Automatic Data Processing
ADP
$97.2B
$585K 0.18%
2,945
+796
+37% +$155K
GOOG icon
119
Alphabet (Google) Class C
GOOG
$4.17T
$584K 0.18%
4,660
+380
+9% +$45.3K
SPHQ icon
120
Invesco S&P 500 Quality ETF
SPHQ
$19.4B
$562K 0.17%
11,567
+6,997
+153% +$325K
AMN icon
121
AMN Healthcare
AMN
$1.33B
$549K 0.17%
5,663
-45
-0.8% -$3.9K
IWF icon
122
iShares Russell 1000 Growth ETF
IWF
$125B
$535K 0.17%
7,876
+1,604
+26% +$103K
QCOM icon
123
Qualcomm
QCOM
$185B
$532K 0.17%
3,723
+146
+4% +$19.7K
BSCN
124
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$531K 0.16%
24,421
+5,295
+28% +$115K
SYY icon
125
Sysco
SYY
$39.3B
$525K 0.16%
6,752

Similar funds

Glen Eagle Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Glen Eagle Advisors held 1,070 positions worth $322M, up 12% from $286M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Glen Eagle Advisors deployed $17M of net new capital in Q2 2021, opening 67 new positions and adding to 247 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 10,640 shares worth $287K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares AAA-A Rated Corporate Bond ETF, an estimated $3.37M trimmed.

  • Glen Eagle Advisors's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 10,640 shares worth $287K.
  • Glen Eagle Advisors added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $2.53M increase.
  • Glen Eagle Advisors's biggest Q2 2021 reduction was iShares AAA-A Rated Corporate Bond ETF, cutting an estimated $3.37M.
  • Glen Eagle Advisors fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $26.9K.
  • Glen Eagle Advisors's ten largest holdings make up 31% of its $322M portfolio in Q2 2021.
  • Glen Eagle Advisors opened 67 new positions and closed 30 in Q2 2021.
  • Glen Eagle Advisors's portfolio value rose 12% quarter-over-quarter to $322M.

Based on Glen Eagle Advisors's 13F filing for Q2 2021, filed 13 Aug 2024.